Evaluation of Value of Contrast-enhanced Ultrasound in Preoperative Staging of Bladder Cancer
Abstract
Objective: To explore the diagnostic value of contrast-enhanced ultrasound in preoperative staging of bladder cancer. Methods: Fiftyfive patients with bladder cancer treated in our hospital from March 2023 to March 2024 were retrospectively selected as study samples.
Contrast-enhanced ultrasound was used for staging diagnosis, and pathological staging was taken as the gold standard to analyze the coincidence rate, sensitivity and specificity of contrast-enhanced ultrasound for staging diagnosis of bladder cancer. Results: In the CEUS group,
the staging accuracy of T1 ~ T4 bladder cancer was 85.00%, 93.75%, 73.33% and 75.00%, respectively, and the sensitivity, specificity,
negative predictive value and positive predictive value of CEUS for T2 stage bladder cancer were 86%, 88%, 72% and 75%, respectively.
Conclusion: Contrast-enhanced ultrasound has a high level of conformity rate in the stage diagnosis of T1 ~ T4 bladder cancer, and has high
sensitivity and specificity in the diagnosis of T2 stage, and has significant application value.
Contrast-enhanced ultrasound was used for staging diagnosis, and pathological staging was taken as the gold standard to analyze the coincidence rate, sensitivity and specificity of contrast-enhanced ultrasound for staging diagnosis of bladder cancer. Results: In the CEUS group,
the staging accuracy of T1 ~ T4 bladder cancer was 85.00%, 93.75%, 73.33% and 75.00%, respectively, and the sensitivity, specificity,
negative predictive value and positive predictive value of CEUS for T2 stage bladder cancer were 86%, 88%, 72% and 75%, respectively.
Conclusion: Contrast-enhanced ultrasound has a high level of conformity rate in the stage diagnosis of T1 ~ T4 bladder cancer, and has high
sensitivity and specificity in the diagnosis of T2 stage, and has significant application value.
Keywords
Contrast-enhanced ultrasound; Patients with bladder cancer; Preoperative staging diagnosis
Full Text:
PDFReferences
[1] SUNG H, FERLAY J, SIEGEL R L, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide
for 36 Cancers in 185 Countries [J]. CA Cancer J Clin, 2021, 71(3): 209-49.
[2] ZHANG G M, SUN H, SHI B, et al. Quantitative CT texture analysis for evaluating histologic grade of urothelial carcinoma [J]. Abdom
Radiol (NY), 2017, 42(2): 561-8.
[3] Ju Zhu. Value of multimodal ultrasound in the classification and staging of bladder cancer [D]. Lanzhou University, 2024.DOI:10.27204/
d.cnki.glzhu. 2023.001499.
[4] Wang Ping, Liu Jian, Yue Wensheng, et al. Value of CEUS in the evaluation of preoperative staging of bladder cancer [J]. Continuing
Medical Education in China, 2018, 10 (11): 55-58.
DOI: http://dx.doi.org/10.70711/mhr.v2i3.4904
Refbacks
- There are currently no refbacks.
